Text Size
22 studies found for:    " April 25, 2012":" May 25, 2012"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Peer-driven Intervention to Seek, Test & Treat Heterosexuals at High Risk for HIV
Conditions: HIV/AIDS;   Vulnerable Populations;   Heterosexuals at High Risk
Interventions: Behavioral: BCAP peer-driven intervention (PDI);   Behavioral: Control intervention
2 Recruiting Alcohol's Impact on Inflammatory Markers in HIV Disease - Russia ARCH Cohort
Conditions: HIV Infection;   Alcohol Use
Intervention:
3 Active, not recruiting Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy
Condition: HIV-infection
Intervention: Drug: Darunavir/ritonavir
4 Recruiting A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV
Condition: HIV Dementia
Interventions: Drug: Long acting methylphenidate;   Drug: Matched placebo
5 Recruiting Safety and Efficacy of Switching a Stable Combined Antiretroviral Therapeutic Regimen to Atazanavir With Ritonavir Plus Lamivudine in Treatment Experienced HIV Positive Patients With Full and Stable Virological Suppression
Condition: Human Immunodeficiency Virus
Interventions: Drug: Atazanavir, ritonavir, lamivudine;   Drug: Atazanavir, Ritonavir, 2 NRTIs
6 Completed A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™
Condition: Infection, Human Immunodeficiency Virus I
Interventions: Drug: Maraviroc;   Drug: Combivir;   Drug: GSK2838510
7 Recruiting Downmodulating Monocyte Activation for HIV-1 Associated Neurocognitive Disorders (HAND)
Condition: HIV Dementia
Interventions: Drug: Atorvastatin (generic Lipitor);   Drug: placebo
8 Recruiting Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients
Condition: HIV-2 Infection
Intervention: Drug: emtricitabine / tenofovir disoproxil fumarate / raltegravir .
9 Not yet recruiting Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer
Conditions: Cervical Cancer;   Acquired Immunodeficiency Syndrome
Interventions: Drug: cisplatin;   Radiation: external beam radiation therapy
10 Active, not recruiting A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1265744 Oral;   Drug: GSK1265744 LAP 800mg intramuscular injection;   Drug: GSK1265744 LAP 200mg subcutaneous injection;   Drug: GSK1265744 LAP 200mg intramuscular injection;   Drug: GSK1265744 LAP 400mg intramuscular injection;   Drug: TMC278 LA 1200mg intramuscular injection;   Drug: TMC278 LA 600mg intramuscular injection
11 Not yet recruiting Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in HIV
Conditions: HIV Infection;   Tuberculosis
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Raltegravir;   Drug: Isoniazid;   Drug: Pyridoxine;   Drug: Pyrazinamide;   Drug: Ethambutol;   Drug: Rifabutin;   Drug: Rifampin
12 Recruiting Fracture and Bone Mineral Density in HIV+ Patients Recently Started on Antiretroviral Therapy (ART)
Conditions: HIV;   Osteoporosis
Intervention:
13 Recruiting Effects of a Protein Calorie Supplement in HIV-infected Women With Tuberculosis
Conditions: HIV;   Tuberculosis
Interventions: Dietary Supplement: Protein calorie supplement;   Dietary Supplement: Micronutrient
14 Recruiting Pharmacokinetics, Pharmacodynamics and Cervicovaginal Lavage of Combined Oral Contraceptives and Raltegravir
Condition: HIV
Intervention:
15 Completed Enhancing HIV Risk Reduction Among Indian Women With Risky Husbands
Condition: Behavioral Risk for HIV
Intervention: Behavioral: RHANI WIves
16 Recruiting A Mixed-Methods Approach to Understanding Factors Associated With Cervical Cancer Screening Utilization Among Low-Income, HIV-Positive Women
Conditions: Cancer Prevention;   Cervix
Interventions: Behavioral: Cognitive Interview;   Behavioral: Questionnaires;   Behavioral: Focus Groups
17 Recruiting Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
Conditions: Diabetic Retinopathy;   HIV
Interventions: Drug: Tesamorelin;   Drug: Placebo-Control
18 Recruiting The Health Access and Recovery Peer Program
Conditions: Hypertension;   Arthritis;   Coronary Artery Disease;   Hepatitis;   Diabetes;   Asthma;   Hyperlipidemia;   HIV
Intervention: Behavioral: HARP Intervention
19 Withdrawn Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone
Condition: HIV
Interventions: Drug: Atazanavir;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Optimized NRTI backbone
20 Recruiting Nucleoside Switch Pilot for Virologically Controlled HIV Subjects With Decreasing CD4 Cells Who Have Received TDF-based ARV Therapy
Condition: HiV1- Positive
Intervention: Drug: Abacavir/Lamivudine
To Top

Previous Page Studies Shown (1-20) Next Page (21-22) Show next page of results
† Indicates status has not been verified in more than two years